This 90-minute webinar is the first of two webinars to highlight the NTCA/APHL Consensus Statement on the Use of Cepheid GeneXpert MTB/RIF Assay. The second webinar is GeneXpert: Examples From the Field.
Favorite
Lab Personnel
Nurses
Physicians
2016
This 90-minute webinar is the first of two webinars to highlight the NTCA/APHL Consensus Statement on the Use of Cepheid GeneXpert MTB/RIF Assay. The second webinar is GeneXpert: Examples From the Field.
Favorite
Lab Personnel
Nurses
Physicians
2016
This fact sheet is a step-by-step guideline discussing the supplies required, limitations and precautions, pharmacokinetics, proper storage, and accurate placement for injection of Amikacin with picture guides. The reverse side features a table covering Amikacin, Streptomycin, and Capreomycin, including information regarding drug information, dosing, side effects, monitoring, contraindications and use in renal disease...
Favorite
Nurses
Physicians
2015
This report is essentially a blueprint on how the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention will achieve its goals to eradicate the diseases they focus on. The report discusses goals, which align with the National HIV/AIDS Strategy, to reduce incidence, health disparities, morbidity, and mortality...
Favorite
Physicians
2015
This manual for clinicians provides guidelines for clinical care of persons with HIV/AIDS. This updated version incorporates many new insights, but the time-tested format has been retained – easy access to crucial facts for a busy clinician. The guide touches on every topic facing people with HIV and their caregivers...
Favorite
Medical and Nursing School Students
Physicians
2014
This pamphlet is a guide for primary care providers who treat individuals and populations that may be at risk for latent TB infection (LTBI). It is not a substitute for the guidelines on testing and treating LTBI, but is a ready and useful reference that highlights the main points of the guidelines...
Favorite
Physicians
2013
This MDR TB online course exists as a free self-learning online tool in allowing physicians worldwide to learn and test their knowledge of MDR TB. It is accredited by the South African Medical Association and the Norwegian Medical Association. The course contains seven modules and covers etiology and pathogenesis of TB, diagnosis and treatment, special situations, patient-physician communication, treatment adherence, and TB infection and control...
Favorite
Physicians
2012
This 120-minute training was held for clinicians and others who are involved in the diagnosis of active TB. There are three presentations and a question and answer session.
Favorite
Nurses
Physicians
2011
This 90-minute webinar was held for clinicians and others who provide services to TB patients or persons at risk for TB with significant alcohol and/or tobacco use.
Favorite
Nurses
Physicians
2011
This information card provides information on the multiple significant drug interactions between TB medications; specifically, INH, rifampin, and other medications and the effect of the interaction. It also provides information on food interactions with TB drugs.
Favorite
Nurses
Outreach Workers
Physicians
2010
This report presents the Centers for Disease Control and Prevention's (CDC) updated recommendations on the use of nucleic acid amplification tests (NAA) for TB diagnosis. These revised guidelines were developed on the basis of a report by a panel of clinicians, laboratorians, and TB control officials...
Favorite
Physicians
2009
This two-hour webinar was developed for clinicians in the United States who may treat or screen patients with tuberculosis, diabetes, or both diseases. The webinar includes a 90-minute presentation and a 30-minute question and answer session.
Favorite
Nurses
Physicians
2009
This report summarizes updated recommendations for managing the drug-drug interactions that occur when using antiretroviral therapy during TB treatment. Changes from previous versions of these guidelines include an effort to obtain and summarize the clinical experience of using specific antiretroviral regimens during TB treatment (not just pharmacokinetic data), a table summarizing the clinical experience with key antiretroviral regimens and providing recommended regimens (Table 1), and sections on treatment for special populations (young children, pregnant women, patients with drug-resistant TB)...
Favorite
Physicians
2007
This report is a TB program evaluation, which is designed to complement the general CDC Introduction to Program Evaluation for Public Health Programs manual. It contains background information, goals and objectives of a TB program, and reasons for evaluating TB prevention and control programs and explains why the CDC evaluation framework should be used...
Favorite
Physicians
2006
This report provides updated uniform criteria for use by public health professionals when reporting the nationally notifiable infectious diseases listed in Part One of this report. A revision date is included for case definitions that have been revised. The case definitions for some infectious conditions not designated as nationally notifiable are included in Part Two of this report...
Favorite
Physicians
1997
